Brief: Sk Biopharmaceuticals Q3 Operating Profit 19.3 Billion Won, Swings To Profit From Year Earlier
08/11/2024 01:22
SK Biopharmaceuticals Co Ltd 326030.KS :
* SK BIOPHARMACEUTICALS: Q3 OPERATING PROFIT 19.3 BILLION
WON,
SWINGS TO PROFIT FROM YEAR EARLIER
Source text: ID:
Further company coverage: 326030.KS
Recent news on SK Biopharmaceuticals
See all newsBrief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
US FDA pauses new enrollment in Biohaven's epilepsy drug trials (updated)
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million
U.S. STOCKS ON THE MOVE-Meta, Kohl's, J.M. Smucker